These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 14972084)

  • 1. Pharmacogenetics of antihypertensive drug response.
    Kreutz R
    Curr Hypertens Rep; 2004 Feb; 6(1):15-20. PubMed ID: 14972084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of antihypertensive drug responses.
    Schwartz GL; Turner ST
    Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive pharmacogenetics: getting the right drug into the right patient.
    Turner ST; Schwartz GL; Chapman AB; Hall WD; Boerwinkle E
    J Hypertens; 2001 Jan; 19(1):1-11. PubMed ID: 11204288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular approaches to individualize antihypertensive drug therapy.
    Hiltunen TP; Kontula K
    Ann Med; 2012 Jun; 44 Suppl 1():S23-9. PubMed ID: 22713145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in pharmacogenomics of drugs acting on hypertension.
    Trotta R; Donati MB; Iacoviello L
    Pharmacol Res; 2004 Apr; 49(4):351-6. PubMed ID: 15202514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic approaches to study the effects of antihypertensive drugs.
    Kamide K; Kawano Y; Rakugi H
    Hypertens Res; 2012 Aug; 35(8):796-9. PubMed ID: 22739423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of blood pressure response to antihypertensive treatment.
    Mellen PB; Herrington DM
    J Hypertens; 2005 Jul; 23(7):1311-25. PubMed ID: 15942450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the pharmacogenetics of treating hypertension.
    Fontana V; Luizon MR; Sandrim VC
    J Hum Hypertens; 2015 May; 29(5):283-91. PubMed ID: 25355012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals.
    Johnson AD; Newton-Cheh C; Chasman DI; Ehret GB; Johnson T; Rose L; Rice K; Verwoert GC; Launer LJ; Gudnason V; Larson MG; Chakravarti A; Psaty BM; Caulfield M; van Duijn CM; Ridker PM; Munroe PB; Levy D; ; ;
    Hypertension; 2011 May; 57(5):903-10. PubMed ID: 21444836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Individual sensitivity to antihypertensive drugs: genetic aspects].
    Minushkina LO; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2005; 45(7):58-65. PubMed ID: 16091664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antihypertensive response to irbesartan treatment from a pharmacogenetic perspective.
    Kurland L
    Minerva Med; 2003 Aug; 94(4):251-8. PubMed ID: 14605589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pharmacogenomic variation of antihypertensive drugs: from population genetics to personalized medicine.
    Polimanti R; Iorio A; Piacentini S; Manfellotto D; Fuciarelli M
    Pharmacogenomics; 2014 Feb; 15(2):157-67. PubMed ID: 24444406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
    Hiltunen TP; Donner KM; Sarin AP; Saarela J; Ripatti S; Chapman AB; Gums JG; Gong Y; Cooper-DeHoff RM; Frau F; Glorioso V; Zaninello R; Salvi E; Glorioso N; Boerwinkle E; Turner ST; Johnson JA; Kontula KK
    J Am Heart Assoc; 2015 Jan; 4(1):e001521. PubMed ID: 25622599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene markers and antihypertensive therapy.
    Turner ST; Schwartz GL
    Curr Hypertens Rep; 2005 Feb; 7(1):21-30. PubMed ID: 15683583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts and molecular mechanisms in pharmacogenetics of essential hypertension.
    Rahman F; Muthaiah N; Kumaramanickavel G
    Indian J Pharmacol; 2021; 53(4):301-309. PubMed ID: 34414909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies.
    Loganathan L; Gopinath K; Sankaranarayanan VM; Kukreti R; Rajendran K; Lee JK; Muthusamy K
    Curr Drug Targets; 2020; 21(1):18-33. PubMed ID: 31393243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics considerations in the control of hypertension.
    Lupoli S; Salvi E; Barcella M; Barlassina C
    Pharmacogenomics; 2015 Nov; 16(17):1951-64. PubMed ID: 26555875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacogenetics and pharmacogenomics. Searching for individual antihypertensive therapy concepts].
    Brand E
    MMW Fortschr Med; 2003 May; 145(19):43-4. PubMed ID: 12813978
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive pharmacogenetics.
    Nogueira JB
    Rev Port Cardiol; 2004 Dec; 23(12):1621-30. PubMed ID: 15732663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.